Medtronic plc
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Geoffrey Straub Martha
- Full Time Employees
- 95,000
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- Building Two, Parkmore Business Park West Galway GA Ireland H91 4K49
- IPO Date
- May 2, 1973
- CIK
- 0001613103
- Website
- medtronic.com
- Similar Companies
- Business
- Medtronic plc (NYSE: MDT) develops, manufactures, and markets a wide range of medical devices and therapies for the treatment of chronic diseases worldwide. The company offers products across four main segments: cardiovascular (including pacemakers, defibrillators, heart valves, and coronary stents under brands such as Evera, Protecta, and CoreValve); medical surgical (featuring surgical navigation systems, endoscopic tools, and stapling devices like Hugo RAS and Valiant NaviCore); neuroscience (encompassing spinal cord stimulators, deep brain stimulation systems, and intrathecal drug delivery pumps such as Incepta and SynchroMed II); and diabetes (primarily continuous glucose monitoring systems, insulin pumps, and related software through the MiniMed and Guardian brands). Medtronic provides services including patient management software, remote monitoring platforms, and clinical decision support tools to healthcare providers, hospitals, clinics, and patients globally. Founded in 1949 and headquartered in Dublin, Ireland, with principal executive offices in Minneapolis, Minnesota, USA, Medtronic operates in more than 150 countries, serving markets in North America, Europe, Asia-Pacific, Latin America, and the Middle East through direct sales forces, distributors, and subsidiaries. The company targets physicians, hospitals, ambulatory surgery centers, and home care settings, with a focus on minimally invasive therapies and digital health solutions. Key subsidiaries include Covidien (acquired in 2015 for surgical and patient monitoring products) and Intersect ENT (recently integrated for sinus implants). In the past 1-2 years, Medtronic has pursued strategic expansions including the FDA approval and U.S. launch of the Hugo robotic-assisted surgery (RAS) system in 2024 for soft tissue indications, building on its European CE Mark; a multi-year collaboration with NVIDIA announced in 2024 to advance AI-enabled therapies using Medtronic's Gigamon data platform; and the acquisition of Mazor Robotics in 2018 followed by ongoing enhancements to its spinal robotics portfolio with the Mazor X Stealth Edition. The company completed a $4.1 billion acquisition of Covidien assets integration and reported expansions in diabetes care via the Simplera Sync sensor FDA clearance in 2024. Medtronic also announced organizational realignments in 2025 to streamline its four operating units amid portfolio optimization efforts.
Company News
Dave Ramsey Says You Need More Than 6% Just to Break Even. Dividend Growth Is One Way to Get There.
Here's Why Medtronic (MDT) Fell More Than Broader Market
Medtronic: Buy The 3% Yield And Strong Free Cash Flow Growth
Medtronic: The Turnaround Is No Longer Quiet
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields
2 Beaten-Down Stocks to Buy Before They Bounce Back
Jim Cramer Called Medtronic a "Quandary." Here's Why He's Exactly Right.
Medtronic: Don't Miss Out On This Dividend Aristocrat Deal Now
Insider Selling: Medtronic (NYSE:MDT) EVP Sells $138,882.95 in Stock
3 Dividend Stocks to Buy and Hold for 10 Years
Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?
BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system
Medtronic Sees AI, Ablation and Targeted M&A Fueling Growth
Medtronic plc (MDT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Integrated Wealth Concepts LLC Sells 6,025 Shares of Medtronic PLC $MDT
Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott